Treatment of Clostridium difficile colitis. Summary of a round table held in Brussels on March, 3rd, 1994.
Due to the growing incidence and the severity of infections due to vancomycin resistant enterococci, it is now recommended to treat mild to moderate cases of Clostridium difficile-associated diarrhoea with metronidazole while maintaining the use of oral vancomycin in serious or life-threatening colitis. Clostridium difficile is a common cause of diarrhoea after antibiotic therapy and induces a spectrum of diseases ranging from mild diarrhoea to pseudomembranous colitis (PMC). It is considered to be the first cause of diarrhoea occurring among hospitalized patients (1).
Delmée
M
M
Université Catholique de Louvain, Unité de Microbiologie, Bruxelles.
Melin
P
P
Peetermans
W
W
Verbist
L
L
Verschraegen
G
G
D016360:Clostridioides difficile; D003015:Clostridium Infections / Q000188:drug therapy*; D003092:Colitis / Q000188:drug therapy* / Q000382:microbiology*; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use*; D014640:Vancomycin / Q000627:therapeutic use
D008795:Metronidazole; D014640:Vancomycin